Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis
Breast cancer metastatic progression to critical secondary sites is the second leading cause of cancer-related mortality in women. While existing therapies are highly effective in combating primary tumors, metastatic disease is generally deemed incurable with a median survival of only 2, 3 years. Ex...
Guardado en:
Autores principales: | Dara Brena, Ming-Bo Huang, Vincent Bond |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8af156e49ea04ffb8c31f27bca39bbac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dynamic Landscape of Extracellular Vesicle-Associated Proteins Is Related to Treatment Response of Patients with Metastatic Breast Cancer
por: Olivia Ruhen, et al.
Publicado: (2021) -
Mechanisms, Diagnosis and Treatment of Bone Metastases
por: Jozef Ban, et al.
Publicado: (2021) -
Radiogenomics: Hunting Down Liver Metastasis in Colorectal Cancer Patients
por: Carolina de la Pinta, et al.
Publicado: (2021) -
Nanotechnology-enhanced immunotherapy for metastatic cancer
por: Peisen Zhang, et al.
Publicado: (2021) -
Metastatic breast cancer: Endocrine therapy landscape reshaped
por: Mohamad Adham Salkeni, et al.
Publicado: (2017)